There we have it in black and white. The CEO of the company that manufactures drugs like Ozempic says that GLP-1 drugs are not a cure-all, and patients will still need other treatments. Surely now Mr. Market will realize that the panicky sell off of RMD is the result of fearmongering. Meanwhile I see the 28% fall in RMD's share priced as one of those rare share market opportunities to 'buy when everyone is fearful'. Its time for me to back up the truck!
A little help from CEO Novo Nordisk, page-2
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$32.78 |
Change
-0.320(0.97%) |
Mkt cap ! $20.91B | |||
| Open | High | Low | Value | Volume |
| $32.74 | $33.07 | $32.74 | $34.25M | 1.041M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1267 | $32.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $32.82 | 2077 | 2 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$32.87 |
Change
-0.320 ( 0.67 %) |
||||
| Open | High | Low | Volume | ||
| $32.77 | $33.07 | $32.77 | 531228 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| RMD (ASX) Chart |